Australia's most trusted
source of pharma news
Friday, 28 November 2025
Friday, 28 November 2025
Subscribe
Login
Secret settlement on blockbuster
A confidential agreement has been reached out of court following a patent dispute over the potential launch of a biosimilar referencing a major PBS blockbuster.
Is women's pay stacking up?
New data from the WGEA reveals how women fare in companies in the pharma sector compared to those across the nation
TODAY
Company grows Med Affairs team
Unveils five roles, part of in a multidisciplinary team set to push higher standards in a space that is under growing scrutiny
TODAY
First pharma worth a trillion dollars
In 2017 this company was worth US$81 billion, today it has an eye-watering market cap that stretches to 13 figures
27 November
GM says goodbye but where's he going?
Leaving a remarkable legacy, this boss offers his team heartfelt thanks but there's still no word on his next move
26 November
Australia's Most Valued pharma is...
Aussie GPs and Specialists were asked to name the companies they valued the most, with one a standout performer
26 November
Doctor calls out $7 Rep sandwich
Critics flamed for questioning the integrity of doctors who accept a pen or a meal alongside pharma medical education
25 November
Latest Jobs
Devices Territory ManagerSenior Product ManagerMedical Sales RepresentativeService AdministratorClinical Research, Business Development Manager - ChinaFreight & Distribution SpecialistWarehouse AssistantTechnical Service & Warehouse Coordinator30 more...
Pharma in Focus Jobs
Marketing & Communications (1)
Sales & Customer Relations (16)
- Devices Territory Manager - Brisbane
- Medical Sales Representative - Wollongong
- Clinical Research, Business Development Manager - China - Shanghai, China
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
- Customer Service Representative - East Brisbane
- Head of Sales - Melbourne, VIC
- Pharmaceutical Sales Representative - Sydney
- Key Account Manager - Brisbane
- Clinical Sales Specialist - Sydney
- Clinical Sales Specialist - Melbourne
- Pharmaceutical Sales Representative - Brisbane
- Customer Service Representative - Belrose
- Inside Sales - Sydney
- Customer Service Representative - St Leonards
- Customer Service Representative - Belrose
- Customer Service Representative - Macquarie Park
Clinical & Medical, R&D (8)
- Medical Sales Representative - Wollongong
- Clinical Research, Business Development Manager - China - Shanghai, China
- Senior Portfolio Director - Clinical Research, China - Shanghai, China
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
- Clinical Sales Specialist - Sydney
- Clinical Sales Specialist - Melbourne
- Clinical Affairs Lead - Sydney
- QC Microbiologist - Broadmeadows
Regulatory, Pharmacovigilance & QA (3)
- Regulatory Affairs Specialist - Sydney
- Senior Quality Assurance Associate - Sydney
- Senior Regulatory Affairs Associate - Sydney
Devices (1)
Executive Roles (3)
- Compliance & Legal Director - Macquarie Park
- Senior Portfolio Director - Clinical Research, China - Shanghai, China
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
Other (15)
- Service Administrator - Belrose
- Freight & Distribution Specialist - Macquarie Park
- Warehouse Assistant - Rydalmere
- Technical Service & Warehouse Coordinator - Alexandria
- Finance Business Partner - Surry Hills
- Senior Payroll Officer - Melbourne
- Head of People and Culture - Kingsgrove
- TM - QLD South Consumables - Brisbane
- Commercial Lead - Melbourne
- Senior Recruitment Consultant - Sydney
- Senior Recruitment Consultant - Sydney
- Warehouse Assistant - Macquarie Park
- People and Culture Manager - Kingsgrove
- Technical Service & Warehouse Coordinator - Alexandria
- Service Administrator - Belrose
Pharma workers rate the Boss
New analysis takes a deep dive into what pharma employees truly think of the CEOs running their companies
27 November
Novo gamble fails to pay off
Long-shot trial in Alzheimer's fails to reduce disease progression but some experts haven't lost hope the drug could help just yet
November 27
Novartis trailblazes private scripts
Streamlined system to supply non-PBS subsidised drugs into the hospital system launches with Novartis the first pharma on board
27 November
Data void hid half of MBC patients
New world-first figures reveal the number of people living with this incurable disease in Australia are twice previous estimates
27 November
Aussie trailblazer lands Novo prize
Seven finalists plus the winner of the inaugural Marie Krogh Prize for Young Women in Science take home $85K in prize money
26 November
TGA bumps up safety warning
70 adverse events linked to discontinued or delayed treatment of this popular PBS drug after a comprehensive investigation
26 November
Early detection avoids ER crisis
New report advocates for expansion of screening trial to avoid a medical emergency for 25,000 Aussies
26 November
Billion dollar 'No' for Lilly drug
A DNA test to determine eligibility for the first disease modifying treatment for this disease was turned down by MSAC
25 November
Compounders target Novartis again
Pharma leapfrogged by a compounder to government funding for a copycat that does not have TGA approval
25 November
Omico warns of mates left behind
Precision oncology can extend life expectancy by half, but only one in five Aussies have access through the current referral system
25 November
Combo proves 'practice-changing'
FDA approves a big-name combo as the first perioperative treatment that improves survival for some types of bladder cancer
25 November
Who'll nab 2025's last PBS listings?
December PBS listings will mark the final reimbursement wins for 2025 and a dozen drugs are jostling for success
24 November
Three blockbusters-to-be hit TGA
Drugs with big sales predictions, including a mega-blockbuster, have landed on the ARTG in a busy week for approvals
24 November Approvals Action
'Fiasco sale' damages deal-making
With the Treasurer handing a US pharma a 'get out of jail free' card, questions are being asked how it will affect future pharma deals in Australia
24 November